Biaryl phosphodiesterase inhibitors
US9051290B2 · kind B2 · utility
0Cited by
1References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2011 |
| Grant date | Jun 9, 2015 |
| Priority date | — |
| Expiry date | Apr 28, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D307/88
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel biaryl compounds with phosphodiesterase inhibitory activity of general formula (I) below, wherein R1, R2, R3, X, Y, Z1, Z2, Z3, and Z4 have the meanings defined herein, as well as their use as therapeutic agents in the treatment of inflammatory diseases and conditions are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.